Frangoul, H., Habtemariam, B., Lo, A., Ambati, S., Chen, Y., Chesler, S., Patel, J., Goyal, S., Simon, A., Gupta, A. (2025). Enhanced CD34+ cell mobilizations, collections, and comparable safety profile with fixed-dose versus weight-based plerixafor dosing in patients with sickle cell disease receiving autologous CD34+ base-edited hematopoietic stem cells (BEAM-101) in the ongoing BEACON study. Blood. https://doi.org/10.1182/blood-2025-1049